493.89MMarket Cap-331P/E (TTM)
16.505High15.700Low485.93KVolume16.400Open16.130Pre Close7.80MTurnover1.57%Turnover RatioLossP/E (Static)31.05MShares23.36052wk High0.13P/B493.89MFloat Cap12.51052wk Low--Dividend TTM31.05MShs Float23.360Historical High--Div YieldTTM4.99%Amplitude12.510Historical Low16.048Avg Price1Lot Size
Grail Stock Forum
GRAIL Advances the Galleri® Registrational Clinical Trial Program
GRAIL (NASDAQ: GRAL) has announced significant progress in its clinical trials for the Galleri® multi-cancer early detection (MCED) test. The company has completed enrollment of over 35,000 participants in the PATHFINDER 2 study across North America and finished the final study visits for the NHS-Galleri trial with more than 140,000 participants in England. Results from the first 25,000 PATHFINDER 2 participan...
No comment yet